Percutaneous Orthotopic Transcatheter Tricuspid Valve Replacement for Native Valve Destruction After Endocarditis.

ABSTRACT:

Background

Transcatheter tricuspid valve replacement (TTVR) is emerging as an option for treating severe tricuspid regurgitation (TR) in patients at high surgical risk.

Case summary

A 59-year-old man with torrential TR and right heart failure following Staphylococcus aureus tricuspid valve infective endocarditis and extensive leaflet destruction was successfully treated with orthotopic TTVR using the LuX-Valve Plus system (Jenscare), resulting in significant clinical improvement and favorable right ventricular remodeling.

Discussion

The LuX-Valve Plus, delivered via transjugular access, enables optimal coaxial alignment during deployment. Its unique features-leaflet graspers, a septal anchoring mechanism, and a flexible frame-provide stability and preserve right ventr

SUBMITTER: Ruberti A 

PROVIDER: S-EPMC12540496 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature